{
  "aggregate": {
    "max_possible_score": 14,
    "percent_score": 64.3,
    "star_display": "★★★",
    "star_rating": 3,
    "total_score": 9
  },
  "company": "AbbVie",
  "company_slug": "abbvie",
  "evidence_breakdown": {
    "by_type": {
      "NARRATIVE": 3,
      "OPERATIONAL": 11,
      "POLICY": 26
    }
  },
  "pillar_scores": {
    "explainability": {
      "best_evidence_type": "POLICY",
      "display_name": "Explainability",
      "evidence_count": 2,
      "findings": "The company's AI governance strategy references vendor explainability.",
      "max_score": 2,
      "path_to_improvement": "Publish user-facing explanation interfaces or documented appeal workflows.",
      "relevant_sources": [
        {
          "artifact_type": "press_release",
          "source_id": "src_002",
          "source_tier": "third_party",
          "summary": "The AbbVie Legal Team AI Governance Strategy press release details AbbVie's approach to responsible AI, providing evidence for **governance**, **oversight**, **transparency**, **explainability**, and **external accountability**. The document highlights structured processes for AI activity, including data sensitivity assessments, cross-functional collaboration, policy reviews, documented risk assessments, and human oversight requirements for AI tools and workflows. It also touches upon vendor explainability and the need for governance frameworks to guide AI adoption and ensure compliance with life sciences regulations.",
          "title": "AbbVie Legal Team AI Governance Strategy",
          "url": "https://emerj.com/transforming-legal-teams-with-ai-to-make-ip-a-growth-driver-with-leaders-from-clarivate-and-abbvie"
        }
      ],
      "score": 1,
      "source_count": 1
    },
    "external_accountability": {
      "best_evidence_type": "POLICY",
      "display_name": "Public Commitments & External Audits",
      "evidence_count": 4,
      "findings": "The company highlights compliance with AI regulations, strategic advice on AI integration, and the establishment of policies for AI management. It also references the need for governance frameworks to guide AI adoption and ensure compliance with life sciences regulations.",
      "max_score": 2,
      "path_to_improvement": "Publish third-party audit results, certifications, or regulatory compliance documentation.",
      "relevant_sources": [
        {
          "artifact_type": "help_page",
          "source_id": "src_001",
          "source_tier": "company_owned",
          "summary": "This job posting for a Senior Legal Counsel, AI provides evidence for **governance**, **external accountability**, **privacy**, and **transparency**. The document details the development of an AI governance framework, policy creation, and risk assessment tools, directly supporting governance and transparency. It also highlights compliance with AI regulations and strategic advice on AI integration, which speaks to external accountability and the establishment of policies for AI management. Furthermore, the emphasis on cross-functional collaboration with privacy and data teams indicates a focus on responsible data handling and privacy considerations within AI implementation.",
          "title": "Senior Legal Counsel, AI Job Posting",
          "url": "https://careers.abbvie.com/en/job/senior-legal-counsel-ai-in-north-chicago-il-jid-10594"
        },
        {
          "artifact_type": "press_release",
          "source_id": "src_002",
          "source_tier": "third_party",
          "summary": "The AbbVie Legal Team AI Governance Strategy press release details AbbVie's approach to responsible AI, providing evidence for **governance**, **oversight**, **transparency**, **explainability**, and **external accountability**. The document highlights structured processes for AI activity, including data sensitivity assessments, cross-functional collaboration, policy reviews, documented risk assessments, and human oversight requirements for AI tools and workflows. It also touches upon vendor explainability and the need for governance frameworks to guide AI adoption and ensure compliance with life sciences regulations.",
          "title": "AbbVie Legal Team AI Governance Strategy",
          "url": "https://emerj.com/transforming-legal-teams-with-ai-to-make-ip-a-growth-driver-with-leaders-from-clarivate-and-abbvie"
        }
      ],
      "score": 1,
      "source_count": 2
    },
    "fairness": {
      "best_evidence_type": null,
      "display_name": "Fairness & Bias Mitigation",
      "evidence_count": 0,
      "findings": null,
      "max_score": 2,
      "path_to_improvement": "Document bias testing procedures or vendor AI fairness requirements.",
      "relevant_sources": [],
      "score": 0,
      "source_count": 0
    },
    "governance": {
      "best_evidence_type": "OPERATIONAL",
      "display_name": "Governance & Accountability",
      "evidence_count": 33,
      "findings": "Documentation details the development of an AI governance framework, policy creation, and risk assessment tools. Structured processes for AI activity are highlighted, including data sensitivity assessments, cross-functional collaboration, policy reviews, and documented risk assessments. The company explicitly mentions AI model governance, defines standards, and develops guidance and frameworks for responsible AI use across the clinical trial lifecycle. The AI/ML implementation process, including model development and scaling, is detailed, and the board's regular review and discussion of AI risks are acknowledged.",
      "max_score": 2,
      "path_to_improvement": null,
      "relevant_sources": [
        {
          "artifact_type": "help_page",
          "source_id": "src_001",
          "source_tier": "company_owned",
          "summary": "This job posting for a Senior Legal Counsel, AI provides evidence for **governance**, **external accountability**, **privacy**, and **transparency**. The document details the development of an AI governance framework, policy creation, and risk assessment tools, directly supporting governance and transparency. It also highlights compliance with AI regulations and strategic advice on AI integration, which speaks to external accountability and the establishment of policies for AI management. Furthermore, the emphasis on cross-functional collaboration with privacy and data teams indicates a focus on responsible data handling and privacy considerations within AI implementation.",
          "title": "Senior Legal Counsel, AI Job Posting",
          "url": "https://careers.abbvie.com/en/job/senior-legal-counsel-ai-in-north-chicago-il-jid-10594"
        },
        {
          "artifact_type": "press_release",
          "source_id": "src_002",
          "source_tier": "third_party",
          "summary": "The AbbVie Legal Team AI Governance Strategy press release details AbbVie's approach to responsible AI, providing evidence for **governance**, **oversight**, **transparency**, **explainability**, and **external accountability**. The document highlights structured processes for AI activity, including data sensitivity assessments, cross-functional collaboration, policy reviews, documented risk assessments, and human oversight requirements for AI tools and workflows. It also touches upon vendor explainability and the need for governance frameworks to guide AI adoption and ensure compliance with life sciences regulations.",
          "title": "AbbVie Legal Team AI Governance Strategy",
          "url": "https://emerj.com/transforming-legal-teams-with-ai-to-make-ip-a-growth-driver-with-leaders-from-clarivate-and-abbvie"
        },
        {
          "artifact_type": "charter",
          "source_id": "src_003",
          "source_tier": "third_party",
          "summary": "This charter from the Council for Responsible Use of AI in Clinical Trials establishes guardrails and shared frameworks for AI safety in clinical research. The document provides evidence for the **governance** pillar by explicitly mentioning AI model governance, defining standards, and developing guidance and frameworks for responsible AI use across the clinical trial lifecycle. This indicates a structured and policy-level commitment to establishing practices and alignment for AI.",
          "title": "Council for Responsible Use of AI in Clinical Trials",
          "url": "https://advarra.com/council-for-responsible-use-of-ai-in-clinical-trials"
        },
        {
          "artifact_type": "blog_post",
          "source_id": "src_004",
          "source_tier": "company_owned",
          "summary": "This company blog post, \"Three Ways AI is Changing Drug Discovery,\" provides evidence for the **governance** and **transparency** pillars of responsible AI. The post supports governance by mentioning ML capabilities and a platform for data centralization, which implies structured AI development. Transparency is evidenced through explanations of AI model capabilities in identifying rules and predicting sequences, the use of LLMs for predicting antibody structures and processing data, and learning patterns to predict new structures, all of which highlight the explainability of AI functionality and application.",
          "title": "Three Ways AI is Changing Drug Discovery",
          "url": "https://abbvie.com/who-we-are/our-stories/three-ways-ai-is-changing-drug-discovery-at-abbvie.html"
        },
        {
          "artifact_type": "help_page",
          "source_id": "src_005",
          "source_tier": "company_owned",
          "summary": "This AbbVie help page for the \"AI & Data Convergence Platform\" provides evidence for **governance** and **transparency**. The page details the platform's use of machine learning for intelligent data processing, regulatory team AI for clinical trial data review, and generative AI for pattern recognition, all of which imply transparency in AI capabilities and governance over their application and data interpretation. The description of AI/ML tools for data centralization and prediction further supports these pillars by indicating transparency and governance in data use and the platform's predictive functions.",
          "title": "AI & Data Convergence Platform",
          "url": "https://abbvie.com/science/areas-of-innovation/ai-and-data-convergence.html"
        },
        {
          "artifact_type": "sec_filing",
          "source_id": "src_006",
          "source_tier": "authority",
          "summary": "The AbbVie 2024 Form 10-K & Proxy Statement supports the **governance** and **oversight** pillars by acknowledging the board's regular review and discussion of AI risks as an evolving area. It also provides evidence for the **privacy** pillar by mentioning board oversight of AI-related privacy concerns.",
          "title": "AbbVie 2024 Form 10-K & Proxy Statement",
          "url": "https://sec.gov/Archives/edgar/data/1551152/000110465925027375/tm252086d2_ars.pdf"
        },
        {
          "artifact_type": "technical_paper",
          "source_id": "src_007",
          "source_tier": "third_party",
          "summary": "This technical paper, \"Clinical Data Transformation: AbbVie's AI Journey,\" provides evidence for **governance**, **oversight**, and **transparency**. It supports governance by detailing the AI/ML implementation process, including model development and scaling. Evidence for oversight is found in the description of \"Human in the Loop\" (HITL) mechanisms for continuous improvement, and transparency is demonstrated through the summarization of AI/ML benefits like automation and accuracy, as well as the outlining of integration steps and system efficiencies.",
          "title": "Clinical Data Transformation: AbbVie's AI Journey",
          "url": "https://pharmasug.org/proceedings/2025/SI/PharmaSUG-2025-SI-180.pdf"
        }
      ],
      "score": 2,
      "source_count": 7
    },
    "oversight": {
      "best_evidence_type": "OPERATIONAL",
      "display_name": "Human Oversight & Accountability",
      "evidence_count": 5,
      "findings": "The company highlights human oversight requirements for AI tools and workflows. It also describes Human in the Loop (HITL) mechanisms for continuous improvement. The board's regular review and discussion of AI risks are acknowledged.",
      "max_score": 2,
      "path_to_improvement": null,
      "relevant_sources": [
        {
          "artifact_type": "press_release",
          "source_id": "src_002",
          "source_tier": "third_party",
          "summary": "The AbbVie Legal Team AI Governance Strategy press release details AbbVie's approach to responsible AI, providing evidence for **governance**, **oversight**, **transparency**, **explainability**, and **external accountability**. The document highlights structured processes for AI activity, including data sensitivity assessments, cross-functional collaboration, policy reviews, documented risk assessments, and human oversight requirements for AI tools and workflows. It also touches upon vendor explainability and the need for governance frameworks to guide AI adoption and ensure compliance with life sciences regulations.",
          "title": "AbbVie Legal Team AI Governance Strategy",
          "url": "https://emerj.com/transforming-legal-teams-with-ai-to-make-ip-a-growth-driver-with-leaders-from-clarivate-and-abbvie"
        },
        {
          "artifact_type": "sec_filing",
          "source_id": "src_006",
          "source_tier": "authority",
          "summary": "The AbbVie 2024 Form 10-K & Proxy Statement supports the **governance** and **oversight** pillars by acknowledging the board's regular review and discussion of AI risks as an evolving area. It also provides evidence for the **privacy** pillar by mentioning board oversight of AI-related privacy concerns.",
          "title": "AbbVie 2024 Form 10-K & Proxy Statement",
          "url": "https://sec.gov/Archives/edgar/data/1551152/000110465925027375/tm252086d2_ars.pdf"
        },
        {
          "artifact_type": "technical_paper",
          "source_id": "src_007",
          "source_tier": "third_party",
          "summary": "This technical paper, \"Clinical Data Transformation: AbbVie's AI Journey,\" provides evidence for **governance**, **oversight**, and **transparency**. It supports governance by detailing the AI/ML implementation process, including model development and scaling. Evidence for oversight is found in the description of \"Human in the Loop\" (HITL) mechanisms for continuous improvement, and transparency is demonstrated through the summarization of AI/ML benefits like automation and accuracy, as well as the outlining of integration steps and system efficiencies.",
          "title": "Clinical Data Transformation: AbbVie's AI Journey",
          "url": "https://pharmasug.org/proceedings/2025/SI/PharmaSUG-2025-SI-180.pdf"
        }
      ],
      "score": 2,
      "source_count": 3
    },
    "privacy": {
      "best_evidence_type": "OPERATIONAL",
      "display_name": "Privacy & Security",
      "evidence_count": 3,
      "findings": "The company emphasizes cross-functional collaboration with privacy and data teams, focusing on responsible data handling and privacy considerations within AI implementation. Board oversight of AI-related privacy concerns is also mentioned.",
      "max_score": 2,
      "path_to_improvement": null,
      "relevant_sources": [
        {
          "artifact_type": "help_page",
          "source_id": "src_001",
          "source_tier": "company_owned",
          "summary": "This job posting for a Senior Legal Counsel, AI provides evidence for **governance**, **external accountability**, **privacy**, and **transparency**. The document details the development of an AI governance framework, policy creation, and risk assessment tools, directly supporting governance and transparency. It also highlights compliance with AI regulations and strategic advice on AI integration, which speaks to external accountability and the establishment of policies for AI management. Furthermore, the emphasis on cross-functional collaboration with privacy and data teams indicates a focus on responsible data handling and privacy considerations within AI implementation.",
          "title": "Senior Legal Counsel, AI Job Posting",
          "url": "https://careers.abbvie.com/en/job/senior-legal-counsel-ai-in-north-chicago-il-jid-10594"
        },
        {
          "artifact_type": "sec_filing",
          "source_id": "src_006",
          "source_tier": "authority",
          "summary": "The AbbVie 2024 Form 10-K & Proxy Statement supports the **governance** and **oversight** pillars by acknowledging the board's regular review and discussion of AI risks as an evolving area. It also provides evidence for the **privacy** pillar by mentioning board oversight of AI-related privacy concerns.",
          "title": "AbbVie 2024 Form 10-K & Proxy Statement",
          "url": "https://sec.gov/Archives/edgar/data/1551152/000110465925027375/tm252086d2_ars.pdf"
        }
      ],
      "score": 2,
      "source_count": 2
    },
    "transparency": {
      "best_evidence_type": "POLICY",
      "display_name": "Transparency",
      "evidence_count": 17,
      "findings": "Documentation describes the development of an AI governance framework, policy creation, and risk assessment tools, alongside structured processes for AI activity. Explanations of AI model capabilities, LLM use, and learning patterns are provided, highlighting the explainability of AI functionality and application. The company also details the use of its AI & Data Convergence Platform for machine learning, regulatory AI, and generative AI, summarizing AI/ML benefits and outlining integration steps.",
      "max_score": 2,
      "path_to_improvement": "Publish detailed documentation (model cards, system specs) for AI systems deployed.",
      "relevant_sources": [
        {
          "artifact_type": "help_page",
          "source_id": "src_001",
          "source_tier": "company_owned",
          "summary": "This job posting for a Senior Legal Counsel, AI provides evidence for **governance**, **external accountability**, **privacy**, and **transparency**. The document details the development of an AI governance framework, policy creation, and risk assessment tools, directly supporting governance and transparency. It also highlights compliance with AI regulations and strategic advice on AI integration, which speaks to external accountability and the establishment of policies for AI management. Furthermore, the emphasis on cross-functional collaboration with privacy and data teams indicates a focus on responsible data handling and privacy considerations within AI implementation.",
          "title": "Senior Legal Counsel, AI Job Posting",
          "url": "https://careers.abbvie.com/en/job/senior-legal-counsel-ai-in-north-chicago-il-jid-10594"
        },
        {
          "artifact_type": "press_release",
          "source_id": "src_002",
          "source_tier": "third_party",
          "summary": "The AbbVie Legal Team AI Governance Strategy press release details AbbVie's approach to responsible AI, providing evidence for **governance**, **oversight**, **transparency**, **explainability**, and **external accountability**. The document highlights structured processes for AI activity, including data sensitivity assessments, cross-functional collaboration, policy reviews, documented risk assessments, and human oversight requirements for AI tools and workflows. It also touches upon vendor explainability and the need for governance frameworks to guide AI adoption and ensure compliance with life sciences regulations.",
          "title": "AbbVie Legal Team AI Governance Strategy",
          "url": "https://emerj.com/transforming-legal-teams-with-ai-to-make-ip-a-growth-driver-with-leaders-from-clarivate-and-abbvie"
        },
        {
          "artifact_type": "blog_post",
          "source_id": "src_004",
          "source_tier": "company_owned",
          "summary": "This company blog post, \"Three Ways AI is Changing Drug Discovery,\" provides evidence for the **governance** and **transparency** pillars of responsible AI. The post supports governance by mentioning ML capabilities and a platform for data centralization, which implies structured AI development. Transparency is evidenced through explanations of AI model capabilities in identifying rules and predicting sequences, the use of LLMs for predicting antibody structures and processing data, and learning patterns to predict new structures, all of which highlight the explainability of AI functionality and application.",
          "title": "Three Ways AI is Changing Drug Discovery",
          "url": "https://abbvie.com/who-we-are/our-stories/three-ways-ai-is-changing-drug-discovery-at-abbvie.html"
        },
        {
          "artifact_type": "help_page",
          "source_id": "src_005",
          "source_tier": "company_owned",
          "summary": "This AbbVie help page for the \"AI & Data Convergence Platform\" provides evidence for **governance** and **transparency**. The page details the platform's use of machine learning for intelligent data processing, regulatory team AI for clinical trial data review, and generative AI for pattern recognition, all of which imply transparency in AI capabilities and governance over their application and data interpretation. The description of AI/ML tools for data centralization and prediction further supports these pillars by indicating transparency and governance in data use and the platform's predictive functions.",
          "title": "AI & Data Convergence Platform",
          "url": "https://abbvie.com/science/areas-of-innovation/ai-and-data-convergence.html"
        },
        {
          "artifact_type": "technical_paper",
          "source_id": "src_007",
          "source_tier": "third_party",
          "summary": "This technical paper, \"Clinical Data Transformation: AbbVie's AI Journey,\" provides evidence for **governance**, **oversight**, and **transparency**. It supports governance by detailing the AI/ML implementation process, including model development and scaling. Evidence for oversight is found in the description of \"Human in the Loop\" (HITL) mechanisms for continuous improvement, and transparency is demonstrated through the summarization of AI/ML benefits like automation and accuracy, as well as the outlining of integration steps and system efficiencies.",
          "title": "Clinical Data Transformation: AbbVie's AI Journey",
          "url": "https://pharmasug.org/proceedings/2025/SI/PharmaSUG-2025-SI-180.pdf"
        }
      ],
      "score": 1,
      "source_count": 5
    }
  },
  "published_at": "2026-02-23T21:41:31Z",
  "run_id": "20260202_201205_e679",
  "schema_version": "1.0",
  "summary": {
    "key_gaps": [
      "Fairness & Bias Mitigation"
    ],
    "key_strengths": [
      "Human Oversight & Accountability",
      "Privacy & Security",
      "Governance & Accountability"
    ],
    "overall_findings": "AbbVie's public disclosures highlight operational practices in governance and oversight. For governance, materials detail the development of an AI governance framework, policy creation, and risk assessment tools, while oversight practices include human oversight requirements for AI tools and workflows. These materials address 6 of 7 evaluated responsible AI pillars, with privacy also showing operational practices such as cross-functional collaboration with privacy and data teams. Transparency, explainability, and external accountability are addressed at the policy level, with published materials describing vendor explainability and compliance with AI regulations. No qualifying public evidence was found for fairness. This assessment draws on 8 publicly available sources.",
    "pillars_operational": 3,
    "pillars_policy_only": 3,
    "pillars_with_evidence": 6,
    "pillars_without_evidence": 1,
    "total_evidence_items": 40,
    "total_sources_used": 7
  }
}
